The compliance bottleneck ends here.
Organizations developing Software as a Medical Device spend 6–12 months in regulatory validation for every release. P4SaMD embeds compliance directly into your workflow; making audit-readiness the default, not the deadline.
The gap between engineering and compliance is costing you.
Most organizations still rely on a fragmented "tool soup": Jira or any ALMs for tasks, Word for documentation, Excel for traceability, GitHub for code. Every handoff between these disconnected systems is a manual, error-prone process that costs days and gradually increases audit risk.
The result: compliance becomes a last-minute effort rather than an ongoing discipline, and product launches slip by months. The hidden cost goes beyond time — it shows up as developer burnout, unexpected regulatory rejections, and audit findings that only emerge after inconsistency has been building for months.
Your current tool stack
Compliant with
Eight capabilities. One platform.
P4SaMD orchestrates your entire SDLC — from requirements to release — with regulatory compliance enforced at every stage.
Built for every stage of the SaMD journey.
Whether you're remediating legacy software, certifying an AI model, or building from scratch — P4SaMD has a proven path.
SaMD Greenfield Development
Building a SaMD from scratch means two simultaneous challenges: writing the software and satisfying the regulator. P4SaMD makes them the same phase.
Building High-Risk AI Software (CDSS)
AI-based clinical software evolves dynamically, but traditional compliance models assume requirements are static. P4SaMD decouples your engineering velocity from regulatory rigidity.
Legacy Regulated Software Remediation
Many organizations hold valuable legacy software trapped by regulatory debt. P4SaMD provides a structured path to certification without rebuilding from scratch.
Every company carries the weight of regulated software.
MedTech Giants
Enterprise organizations modernizing fragmented legacy software estates into a unified, compliant digital health platform.
Life Sciences Enterprises
Global pharma and biotech companies launching digital companions and Patient Support Programs alongside drug releases.
AI-Native Scaleups
Series B to IPO-stage companies building and continuously improving clinical AI models without sacrificing engineering velocity.
Pre-Market Startups
Seed-to-Series A teams building their Design History File and first regulated product on the path to FDA clearance.
Ready to ship compliant software faster?
Join the teams building the next generation of regulated medical software.
Request a Demo →